Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents (at least 12 years of age) and weighing at least 35 kg. APRETUDE tablets may be used as an oral lead-in to assess the tolerability of cabotegravir prior to administration of cabotegravir injections or as short-term oral PrEP in individuals who will miss planned dosing with cabotegravir injections. Individuals must have a documented negative HIV-1 test prior to initiating APRETUDE for HIV-1 PrEP.

Apretude Indications/Uses

cabotegravir

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma